Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (181-190 of 458) with videos related to

Pageof 46
Sort By:
HIV/AIDS (Auckland, N.Z.)|February 21, 2012
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settingsJanice Soo Fern Lee, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Frontiers in Global Women'S Health|November 24, 2021
Integrating Sexual and Reproductive Health Services Within HIV Services: WHO GuidanceNathan Ford, Morkor Newman, Sarai Malumo, et al.
Lancet (London, England)|July 2, 2002
Drug development for neglected diseases: a deficient market and a public-health policy failurePatrice Trouiller, Piero Olliaro, Els Torreele, et al.
Bulletin of the World Health Organization|January 25, 2012
Counting children: comparing reporting for paediatric HIV and tuberculosisPhilipp du Cros, Bern-Thomas Nyang'wa, Marianne Gale, et al.
Journal of Hepatology|December 3, 2014
Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settingsNathan Ford, Tracy Swan, Peter Beyer, et al.
Plos One|January 4, 2013
Antiretroviral therapy outcomes among adolescents and youth in rural ZimbabweHelen Bygrave, Judith Mtangirwa, Kwenzakwenkosi Ncube, et al.
The Lancet. HIV|June 8, 2025
Retiring the language of first-line and second-line ARTMarco Vitoria, Graeme Meintjes, Nathan Ford, et al.
Plos One|May 21, 2010
Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohortNathan Ford, Marta Darder, Tim Spelman, et al.
International Health|September 14, 2013
Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic reviewTom Decroo, Freya Rasschaert, Barbara Telfer, et al.
International Health|September 17, 2013
Risk factors and true outcomes for lost to follow-up individuals in an antiretroviral treatment programme in Tete, MozambiqueCaroline Caluwaerts, Rosa Maendaenda, Fernando Maldonado, et al.
Pageof 46

Showing results (181-190 of 458) with videos related to

Sort By:
Pageof 46
HIV/AIDS (Auckland, N.Z.)|February 21, 2012
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settingsJanice Soo Fern Lee, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Frontiers in Global Women'S Health|November 24, 2021
Integrating Sexual and Reproductive Health Services Within HIV Services: WHO GuidanceNathan Ford, Morkor Newman, Sarai Malumo, et al.
Lancet (London, England)|July 2, 2002
Drug development for neglected diseases: a deficient market and a public-health policy failurePatrice Trouiller, Piero Olliaro, Els Torreele, et al.
Bulletin of the World Health Organization|January 25, 2012
Counting children: comparing reporting for paediatric HIV and tuberculosisPhilipp du Cros, Bern-Thomas Nyang'wa, Marianne Gale, et al.
Journal of Hepatology|December 3, 2014
Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settingsNathan Ford, Tracy Swan, Peter Beyer, et al.
Plos One|January 4, 2013
Antiretroviral therapy outcomes among adolescents and youth in rural ZimbabweHelen Bygrave, Judith Mtangirwa, Kwenzakwenkosi Ncube, et al.
The Lancet. HIV|June 8, 2025
Retiring the language of first-line and second-line ARTMarco Vitoria, Graeme Meintjes, Nathan Ford, et al.
Plos One|May 21, 2010
Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohortNathan Ford, Marta Darder, Tim Spelman, et al.
International Health|September 14, 2013
Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic reviewTom Decroo, Freya Rasschaert, Barbara Telfer, et al.
International Health|September 17, 2013
Risk factors and true outcomes for lost to follow-up individuals in an antiretroviral treatment programme in Tete, MozambiqueCaroline Caluwaerts, Rosa Maendaenda, Fernando Maldonado, et al.
Pageof 46